BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17932968)

  • 1. Determination of serologic and genetic markers aid in the determination of the clinical course and severity of patients with IBD.
    Devlin SM; Dubinsky MC
    Inflamm Bowel Dis; 2008 Jan; 14(1):125-8; discussion 132-3. PubMed ID: 17932968
    [No Abstract]   [Full Text] [Related]  

  • 2. Serologic and genetic markers do not aid in the determination of the clinical course and severity of patients with inflammatory bowel disease.
    Murphy SJ; Kornbluth A
    Inflamm Bowel Dis; 2008 Jan; 14(1):129-31; discussion 132-3. PubMed ID: 17932969
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological markers in inflammatory bowel disease: practical consideration for clinicians.
    Mendoza JL; Abreu MT
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S158-73. PubMed ID: 20117339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the role of serological markers in the diagnosis of IBD?
    Dubinsky MC
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S185-6. PubMed ID: 18816787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can serologic markers help determine prognosis and guide therapy?
    Dubinsky M
    Dig Dis; 2010; 28(3):424-8. PubMed ID: 20926867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markers that differentiate early from late IBD.
    Huang C; Kugathasan S
    Dig Dis; 2012; 30(4):380-2. PubMed ID: 22796800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of serological and genetic markers in inflammatory bowel disease; strength and weakness of the studies.
    Peña AS
    Rev Esp Enferm Dig; 2003 Nov; 95(11):752-4, 749-51. PubMed ID: 14640872
    [No Abstract]   [Full Text] [Related]  

  • 8. Have genomic discoveries in inflammatory bowel disease translated into clinical progress?
    Weizman AV; Silverberg MS
    Curr Gastroenterol Rep; 2012 Apr; 14(2):139-45. PubMed ID: 22302508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory bowel diseases: where we are and where we should go.
    Tonutti E; Agostinis P; Bizzaro N
    Clin Chem Lab Med; 2014 Apr; 52(4):463-5. PubMed ID: 24583463
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of autoantibodies in inflammatory bowel disease.
    Herszényi L; Tulassay Z
    Dig Dis; 2012; 30(2):201-7. PubMed ID: 22722439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serologic markers in inflammatory bowel disease: tools for better diagnosis and disease stratification.
    Dotan I
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):265-74. PubMed ID: 19072419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Markers Associated with Clinical Outcomes in Patients with Inflammatory Bowel Disease.
    Yamamoto-Furusho JK; Fonseca-Camarillo G
    Inflamm Bowel Dis; 2015 Nov; 21(11):2683-95. PubMed ID: 26244649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological markers in inflammatory bowel disease: a review of their clinical utility.
    Barahona-Garrido J; Sarti HM; Barahona-Garrido MK; Hernández-Calleros J; Coss-Adame E; Garcia-Saenz SM; Yamamoto-Furusho JK
    Rev Gastroenterol Mex; 2009; 74(3):230-7. PubMed ID: 19858012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy.
    Jiang W; Li X
    Mol Diagn Ther; 2015 Jun; 19(3):141-58. PubMed ID: 25990388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Modalities for Inflammatory Bowel Disease: Serologic Markers and Endoscopy.
    Clark C; Turner J
    Surg Clin North Am; 2015 Dec; 95(6):1123-41, v. PubMed ID: 26596918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biomarkers in the diagnosis and therapy of inflammatory bowel diseases].
    Iijima H; Shinzaki S; Tsujii M; Takehara T
    Nihon Rinsho; 2012 May; 70(5):869-73. PubMed ID: 22620015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic biomarkers in inflammatory bowel disease].
    Kanmura S; Sakiyama T; Uto H; Tsubouchi H
    Nihon Rinsho; 2012 May; 70(5):790-5. PubMed ID: 22620002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory bowel diseases and Takayasu's arteritis: coincidence or association?
    Kilic L; Kalyoncu U; Karadag O; Akdogan A; Dogan I; Bilgen SA; Kiraz S; Ertenli I
    Int J Rheum Dis; 2016 Aug; 19(8):814-8. PubMed ID: 26913584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serologic markers: impact on early diagnosis and disease stratification in inflammatory bowel disease.
    Arai R
    Postgrad Med; 2010 Jul; 122(4):177-85. PubMed ID: 20675980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serologic markers in inflammatory bowel disease (IBD).
    Nakamura RM; Barry M
    MLO Med Lab Obs; 2001 Nov; 33(11):8-15; quiz 16-9. PubMed ID: 11721286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.